...
首页> 外文期刊>Antioxidants and redox signalling >Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP+ Toxicity-Induced Parkinson's Disease Models
【24h】

Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP+ Toxicity-Induced Parkinson's Disease Models

机译:在MPP +毒性诱导的帕金森氏病模型中抑制过度氧化蛋白折叠具有保护作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims: Protein misfolding occurs in neurodegenerative diseases, including Parkinson's disease (PD). In endoplasmic reticulum (ER), an overload of misfolded proteins, particularly alpha-synuclein (alpha Syn) in PD, may cause stress and activate the unfolded protein response (UPR). This UPR includes activation of chaperones, such as protein disulphide isomerase (PDI), which assists refolding and contributes to removal of unfolded proteins. Although up-regulation of PDI is considered a protective response, its activation is coupled with increased activity of ER oxidoreductin 1 (Ero1), producing harmful hydroperoxide. The objective of this study was to assess whether inhibition of excessive oxidative folding protects against neuronal death in well-established 1-methyl-4-phenylpyridinium (MPP+) models of PD. Results: We found that the MPP+ neurotoxicity and accumulation of aSyn in the ER are prevented by inhibition of PDI or Ero1 alpha. The MPP+ neurotoxicity was associated with a reductive shift in the ER, an increase in the reduced form of PDI, an increase in intracellular Ca2+, and an increase in Ca2+-sensitive calpain activity. All these MPP+-induced changes were abolished by inhibiting PDI. Importantly, inhibition of PDI resulted in increased autophagy, and it prevented MPP+-induced death of dopaminergic neurons in Caenorhabditis elegans. Innovation and Conclusion: Our data indicate that although inhibition of PDI suppresses excessive protein folding and ER stress, it induces clearance of aggregated aSyn by autophagy as an alternative degradation pathway. These findings suggest a novel model explaining the contribution of ER dysfunction to MPP+-induced neurodegeneration and highlight PDI inhibitors as potential treatment in diseases involving protein misfolding.
机译:目的:蛋白质错误折叠发生在神经退行性疾病中,包括帕金森氏病(PD)。在内质网(ER)中,错误折叠的蛋白质(尤其是PD中的α-突触核蛋白(αSyn))的过载可能会引起压力并激活未折叠的蛋白质反应(UPR)。此UPR包括伴侣蛋白(例如蛋白二硫键异构酶(PDI))的激活,这有助于重新折叠并有助于去除未折叠的蛋白。尽管PDI的上调被认为是一种保护性反应,但其激活与ER氧化还原蛋白1(Ero1)的活性增加有关,产生有害的氢过氧化物。这项研究的目的是评估在成熟的PD 1-甲基-4-苯基吡啶(MPP +)模型中抑制过度的氧化折叠是否可以防止神经元死亡。结果:我们发现,通过抑制PDI或Ero1 alpha可以预防ER中的MPP +神经毒性和aSyn的积累。 MPP +神经毒性与ER的减少,PDI还原形式的增加,细胞内Ca2 +的增加以及Ca2 +敏感性钙蛋白酶活性的增加有关。通过抑制PDI消除了所有这些MPP +诱导的变化。重要的是,抑制PDI导致自噬增加,并阻止了MPP +导致秀丽隐杆线虫多巴胺能神经元死亡。创新和结论:我们的数据表明,尽管抑制PDI可以抑制过度的蛋白质折叠和内质网应激,但它会通过自噬作为替代降解途径诱导聚集的aSyn清除。这些发现提示了一个新颖的模型来解释ER功能障碍对MPP +诱导的神经变性的作用,并着重强调了PDI抑制剂作为涉及蛋白质错误折叠的疾病的潜在治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号